JPH0987155A - Ultraviolet light absorber and skin preparation for external use obtained by blending the same - Google Patents
Ultraviolet light absorber and skin preparation for external use obtained by blending the sameInfo
- Publication number
- JPH0987155A JPH0987155A JP7274784A JP27478495A JPH0987155A JP H0987155 A JPH0987155 A JP H0987155A JP 7274784 A JP7274784 A JP 7274784A JP 27478495 A JP27478495 A JP 27478495A JP H0987155 A JPH0987155 A JP H0987155A
- Authority
- JP
- Japan
- Prior art keywords
- garcinia
- mangosteen
- plant
- linn
- ultraviolet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000006097 ultraviolet radiation absorber Substances 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 229940124543 ultraviolet light absorber Drugs 0.000 title abstract 3
- 238000002156 mixing Methods 0.000 title description 2
- 240000006053 Garcinia mangostana Species 0.000 claims abstract description 82
- 235000017048 Garcinia mangostana Nutrition 0.000 claims abstract description 81
- 239000000284 extract Substances 0.000 claims abstract description 36
- 241000593508 Garcinia Species 0.000 claims abstract description 27
- 235000000885 Garcinia xanthochymus Nutrition 0.000 claims abstract description 27
- 241000196324 Embryophyta Species 0.000 claims abstract description 23
- 240000003487 Garcinia parvifolia Species 0.000 claims abstract description 5
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 244000245602 Garcinia atroviridis Species 0.000 claims abstract description 3
- 241001051052 Garcinia bancana Species 0.000 claims abstract description 3
- 241001051041 Garcinia griffithii Species 0.000 claims abstract description 3
- 241000546193 Clusiaceae Species 0.000 claims description 11
- 239000002250 absorbent Substances 0.000 claims description 10
- 230000002745 absorbent Effects 0.000 claims description 10
- 239000006096 absorbing agent Substances 0.000 claims description 9
- 239000000419 plant extract Substances 0.000 claims description 9
- 240000004260 Garcinia hombroniana Species 0.000 claims description 6
- 241000018898 Gardinia Species 0.000 claims description 4
- 241000546188 Hypericum Species 0.000 claims description 4
- 241001051053 Garcinia cowa Species 0.000 claims description 3
- 241001051039 Garcinia forbesii Species 0.000 claims description 3
- 235000016878 Garcinia hombroniana Nutrition 0.000 claims description 3
- 241000041845 Garcinia merguensis Species 0.000 claims description 3
- 241001051118 Garcinia nigrolineata Species 0.000 claims description 3
- 235000016877 Garcinia prainiana Nutrition 0.000 claims description 3
- 240000008016 Garcinia prainiana Species 0.000 claims description 3
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 3
- 241000832224 Hypericaceae Species 0.000 claims description 2
- QTDMGAWIBXJNRR-UHFFFAOYSA-N Mangostin Natural products CC(=CCc1c(O)cc2Oc3cc(C)c(O)c(CC=C(C)C)c3C(=O)c2c1O)C QTDMGAWIBXJNRR-UHFFFAOYSA-N 0.000 claims description 2
- GNRIZKKCNOBBMO-UHFFFAOYSA-N alpha-mangostin Chemical compound OC1=C(CC=C(C)C)C(O)=C2C(=O)C3=C(CC=C(C)C)C(OC)=C(O)C=C3OC2=C1 GNRIZKKCNOBBMO-UHFFFAOYSA-N 0.000 claims description 2
- 244000144730 Amygdalus persica Species 0.000 claims 1
- 235000006040 Prunus persica var persica Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 239000006071 cream Substances 0.000 abstract description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract description 9
- 239000002904 solvent Substances 0.000 abstract description 5
- 239000007788 liquid Substances 0.000 abstract description 3
- 239000006210 lotion Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 244000306015 Garcinia dioica Species 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 50
- 239000012071 phase Substances 0.000 description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 35
- 239000003921 oil Substances 0.000 description 29
- 235000019198 oils Nutrition 0.000 description 29
- 239000000203 mixture Substances 0.000 description 27
- 235000019441 ethanol Nutrition 0.000 description 23
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 20
- 238000009472 formulation Methods 0.000 description 19
- 239000008213 purified water Substances 0.000 description 19
- 239000008346 aqueous phase Substances 0.000 description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 15
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 14
- -1 isopropyl isopropyl Chemical group 0.000 description 14
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 12
- 239000000839 emulsion Substances 0.000 description 11
- 229940058015 1,3-butylene glycol Drugs 0.000 description 10
- 238000000862 absorption spectrum Methods 0.000 description 10
- 235000019437 butane-1,3-diol Nutrition 0.000 description 10
- 238000000605 extraction Methods 0.000 description 10
- 239000002304 perfume Substances 0.000 description 10
- 239000003755 preservative agent Substances 0.000 description 9
- 230000002335 preservative effect Effects 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 229960000541 cetyl alcohol Drugs 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 235000021355 Stearic acid Nutrition 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 7
- 239000008117 stearic acid Substances 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- 229940057995 liquid paraffin Drugs 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 238000011085 pressure filtration Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000000475 sunscreen effect Effects 0.000 description 6
- 239000000516 sunscreening agent Substances 0.000 description 6
- 239000004408 titanium dioxide Substances 0.000 description 6
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 5
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 150000005846 sugar alcohols Polymers 0.000 description 5
- 229940099259 vaseline Drugs 0.000 description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 229940042585 tocopherol acetate Drugs 0.000 description 4
- 229910052724 xenon Inorganic materials 0.000 description 4
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 4
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000000440 bentonite Substances 0.000 description 3
- 229910000278 bentonite Inorganic materials 0.000 description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 3
- 229940067596 butylparaben Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 3
- 229940055577 oleyl alcohol Drugs 0.000 description 3
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 3
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 3
- 229960001173 oxybenzone Drugs 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 2
- 240000006108 Allium ampeloprasum Species 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 235000001424 Garcinia dulcis Nutrition 0.000 description 2
- 244000287680 Garcinia dulcis Species 0.000 description 2
- 241001207030 Garcinia eugeniifolia Species 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- 238000005562 fading Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- CRBBOOXGHMTWOC-NPDDRXJXSA-N 1,4-Anhydro-6-O-dodecanoyl-2,3-bis-O-(2-hydroxyethyl)-D-glucitol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](OCCO)[C@H]1OCCO CRBBOOXGHMTWOC-NPDDRXJXSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 235000016790 Allium chinense Nutrition 0.000 description 1
- 244000295724 Allium chinense Species 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 240000000724 Berberis vulgaris Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 241001364581 Garcinia morella Species 0.000 description 1
- 241001554567 Garcinia subelliptica Species 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 241000282816 Giraffa camelopardalis Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000004565 Indian gamboge tree Nutrition 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 244000195452 Wasabia japonica Species 0.000 description 1
- 235000000760 Wasabia japonica Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- GZSSFSARCMSPPW-UHFFFAOYSA-N butane-2,2-diol Chemical compound CCC(C)(O)O GZSSFSARCMSPPW-UHFFFAOYSA-N 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical class O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- CFSSWEQYBLCBLH-UHFFFAOYSA-N iso-hexadecyl alcohol Natural products CC(C)CCCCCCCCCCCCCO CFSSWEQYBLCBLH-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N p-hydroxybenzoic acid propyl ester Natural products CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940048730 senega Drugs 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 238000004454 trace mineral analysis Methods 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は紫外線吸収剤及びそ
れを配合した皮膚外用剤、特に植物抽出物含有成分を主
成分とする紫外線吸収剤及び皮膚外用剤に関するもので
ある。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an ultraviolet absorbent and a skin external preparation containing the same, and more particularly to an ultraviolet absorbent and a skin external preparation containing a plant extract-containing component as a main component.
【0002】[0002]
【従来の技術】太陽光線に含まれる紫外線は、皮膚科学
的には400nm〜320nmの長波長紫外線(UV−
A)、320nm〜290nm中波長紫外線(UV−
B)、290nm以下の短波長紫外線(UV−C)に分
類される。このうち、290nm以下の波長の紫外線
は、オゾン層によって吸収され、地表に到達しない。2. Description of the Related Art Ultraviolet rays contained in sunlight are dermatologically long wavelength ultraviolet rays (UV-) of 400 nm to 320 nm.
A), 320 nm to 290 nm medium wavelength ultraviolet light (UV-
B) Classified as short wavelength ultraviolet rays (UV-C) of 290 nm or less. Of these, ultraviolet rays having a wavelength of 290 nm or less are absorbed by the ozone layer and do not reach the surface of the earth.
【0003】地表に届く紫外線は、人間の皮膚に様々な
影響を及ぼす。地上にまで達する紫外線の内で、UV−
Bは皮膚の紅班や水泡を形成し、メラニン形成も促進す
る。一方、UV−Aは皮膚の褐色化を惹起し、皮膚の弾
力性の低下及びシワの発生を促進し急激な老化をもたら
す。また、紅班反応の開始を促進し、或いはある種の患
者に対してはこの反応を増強し、更に光毒性或いは光ア
レルギー反応の原因とさえなり得る。このような紫外線
の有害性から皮膚を保護するために、各種紫外線吸収剤
が開発されてきた。Ultraviolet rays reaching the surface of the earth have various effects on human skin. Of the ultraviolet rays that reach the ground, UV-
B forms erythema and blisters on the skin and promotes melanin formation. On the other hand, UV-A causes browning of the skin, lowers the elasticity of the skin and promotes the generation of wrinkles, resulting in rapid aging. It can also accelerate the onset of the erythema reaction, or enhance this reaction for some patients, and even cause phototoxicity or even a photoallergic reaction. Various ultraviolet absorbers have been developed to protect the skin from such harmful effects of ultraviolet rays.
【0004】化学合成による多種多様な紫外線吸収剤と
しては、例えば、ジベンゾイルメタン誘導体、ベンゾフ
ェノン誘導体、ウロカニン酸、p−アミノ安息香酸、2
−エチルヘキシルp−ジメチルアミノベンゾエートなど
が挙げられ、これらは紫外線の予防に用いられている。As a wide variety of UV absorbers obtained by chemical synthesis, for example, dibenzoylmethane derivatives, benzophenone derivatives, urocanic acid, p-aminobenzoic acid, 2
-Ethylhexyl p-dimethylaminobenzoate and the like are used, and these are used for prevention of ultraviolet rays.
【0005】[0005]
【発明が解決しようとする課題】しかしながら、従来の
化学合成による紫外線吸収剤を配合した日焼け防止化粧
料は光感作性等の点で皮膚に対する安全性に問題があ
り、配合量が制限されるなど化粧品原料の中では最も問
題のある薬剤である。一方、天然物由来のものは一般に
作用が温和で安全性が高く、多量に配合することも可能
であるが、紫外線吸収剤としては吸収波長が270nm
以下の短波長の紫外線を吸収するものが多く、皮膚に対
する影響が最も問題となるUV−A及び/又はUV−B
領域の波長の紫外線を吸収するものは余り知られておら
ず、しかも十分な紫外線吸収効果を発揮するものは得ら
れていなかった。However, the conventional sunscreen cosmetics containing a UV absorber by chemical synthesis have a problem in safety to the skin in terms of photosensitization property, and the amount thereof is limited. It is the most problematic drug among cosmetic ingredients. On the other hand, those derived from natural products generally have a mild action and are highly safe, and it is possible to add a large amount thereof, but as an ultraviolet absorber, the absorption wavelength is 270 nm.
UV-A and / or UV-B, which mostly absorbs the following short-wavelength UV rays, and whose effect on the skin is most problematic
Very few have been known to absorb ultraviolet rays having a wavelength in the region, and none have exhibited sufficient ultraviolet ray absorption effect.
【0006】さらに、天然に由来する紫外線吸収剤は光
安定性に著しく欠けるものが多く、現実に紫外線吸収剤
として使用することは極めて困難な物質がほとんどであ
った。すなわち、紫外線吸収剤が配合される製品は暗所
中に保存されるものの方が少なく、しかも使用時は光が
照射される場面で使用されるのであるから、単に紫外線
吸収能を有するというだけでは紫外線吸収剤たり得ず、
優れた光安定性が要求される。本発明はこのような従来
技術の課題に鑑みなされたものであり、その目的は安全
性に優れ、かつUV−A及び/又はUV−B領域におけ
る紫外線吸収効果が高く、しかも光に対して安定な紫外
線吸収剤及びこれを含有する皮膚外用剤を提供すること
にある。[0006] Furthermore, most of the UV absorbers derived from nature have a markedly lacking photostability, and in reality, most of the substances are extremely difficult to use as UV absorbers. That is, since the product containing the ultraviolet absorber is less stored in the dark, and moreover, it is used in a scene where it is irradiated with light during use, it is not possible to simply have an ultraviolet absorbing ability. Can't be an ultraviolet absorber,
Excellent light stability is required. The present invention has been made in view of the problems of the prior art as described above, and the object thereof is excellent safety, a high ultraviolet absorption effect in the UV-A and / or UV-B region, and stable to light. Another object of the present invention is to provide a novel ultraviolet absorber and a skin external preparation containing the same.
【0007】[0007]
【課題を解決するための手段】本発明者らは、前記目的
を達成するために鋭意検討した結果、オトギリソウ科植
物、特にフクギ属植物の果皮からの抽出画分に優れた紫
外線吸収能を有する物質が存在することを見い出し、本
発明を完成するに至った。すなわち、本発明の紫外線吸
収剤は、一つにはマンゴスチンを有効成分として含有す
ることを特徴とする。Means for Solving the Problems As a result of intensive studies for achieving the above-mentioned object, the present inventors have an excellent ultraviolet absorption ability in the extract fraction from the peel of Hypericumaceae plants, especially the asteraceae plants. The existence of substances was found, and the present invention was completed. That is, one feature of the ultraviolet absorbent of the present invention is that it contains mangosteen as an active ingredient.
【0008】また、本発明の紫外線吸収剤は、一つには
オトギリソウ科植物(Guttiferae A.L. deJuss)のマンゴ
スチン含有画分を配合したことを特徴とする。また、本
発明の紫外線吸収剤は、一つには前記オトギリソウ科植
物(Guttiferae A. L. deJuss)がフクギ属(Garcinia Lin
n.)植物であることを特徴とする。Further, one feature of the ultraviolet absorbent of the present invention is that it contains a mangosteen-containing fraction of a plant of the family Hypericum ( Guttiferae AL de Juss). In addition, one of the UV absorbers of the present invention is that the plant of the family Hypericumaceae ( Guttiferae AL de Juss) belongs to the genus Garcinia Lin.
n.) It is characterized by being a plant.
【0009】また、本発明の紫外線吸収剤は、一つには
前記オトギリソウ科植物(Guttiferae A. L. deJuss)が
フクギ属(Garcinia Linn.)に属するマンゴスチン(Garci
nia mangostana Linn.)、グルグル(Garcinia atrovirid
is Griff.ex T. Anders.)、バンカマンギス(Garcinia b
ancana Miq.)、コバノマンギス(Garcinia brevirostris
Scheff.)、ゴラカ(Garcinia cambogia Desr.)、セレベ
スマンゴスチン(Garcinia celebica Linn.)、コーワガ
ンボジ(Garcinia cowa Roxb.)、ムムンジン(Garcinia d
ioica Blume.)、オオバノマンゴスチン(Garcinia dulci
s. Kurz.)、アカミカンジス(Garcinia forbesii Kin
g.)、カンジス(Garcinia globulosa Rindl.)、キミノマ
ンギス(Garcinia griffithii T. Anders.)、ガンボジ(G
arcinia hauburyi Hook. f.)、ハママンゴスチン(Garci
nia hombroniana Pierre)、メルギーカンジス(Garcinia
merguensis Wight)、インドガムボジ(Garcinia morell
a Desr.)、ツノミマンギス(Garcinia nigrolineata Pla
nch.ex T. Anders.)、コバノカンジス(Garcinia parvif
olia Miq.)、ボタンマンゴスチン(Garcinia prainiana
King)、フクギ(Garcinia subelliptica Merrill)、キヤ
ニモモ(Garcinia xanthochymus Hook f.)の中から選ば
れた少なくとも1種以上の植物抽出物であることを特徴
とする。[0009] The ultraviolet absorbent of the present invention, in part mangosteen belonging to the hypericaceae plants (Guttiferae AL deJuss) is Garcinia (Garcinia Linn.) (Garci
nia mangostana Linn.), Garcinia atrovirid
is Griff.ex T. Anders.), Bangka Manggis ( Garcinia b )
ancana Miq.), Kobano Manggis ( Garcinia brevirostris )
Scheff.), Goraka ( Garcinia cambogia Desr.), Celebes Mangosteen ( Garcinia celebica Linn.), Kowa Gamboji ( Garcinia cowa Roxb.), Mumunjin ( Garcinia d )
ioica Blume.), Obana mangosteen ( Garcinia dulci
s. Kurz.), Akamikanjisu (Garcinia forbesii Kin
g.), Kanjisu (Garcinia globulosa Rindl.), Kiminomangisu (Garcinia griffithii T. Anders.), Ganboji (G
arcinia hauburyi Hook. f.), Hama Mangosteen ( Garci
nia hombroniana Pierre), Merugikanjisu (Garcinia
merguensis Wight), Indogamuboji (Garcinia morell
a Desr.), Tsunomimangisu (Garcinia nigrolineata Pla
nch.ex T. Anders.), Covanocandis ( Garcinia parvif )
olia Miq.), button mangosteen ( Garcinia prainiana
King), Fukugi ( Gardinia subelliptica Merrill), and Carrot ( Gardinia xanthochymus Hook f.), Which is at least one kind of plant extract.
【0010】また、本発明の紫外線吸収剤は、一つには
前記オトギリソウ科植物(Guttiferae A. L. deJuss)が
フクギ属(Garcinia Linn.)に属するマンゴスチン(Garci
nia mangostana Linn.)であることを特徴とする。ま
た、本発明の紫外線吸収剤は、一つには前記オトギリソ
ウ科植物(Guttiferae A. L. deJuss)のマンゴスチン含
有画分が該植物の果皮からの抽出画分であることを特徴
とする。本発明の紫外線吸収性皮膚外用剤は、一つには
前記紫外線吸収剤を配合したことを特徴とするものであ
り、また、一つにはマンゴスチン(Garcinia mangostana
Linn.)の抽出物を配合したことを特徴とする。The ultraviolet absorber of the present invention includes, in part, the mangosteen ( Garci ) belonging to the genus Garcinia Linn., Which is a plant of the family Hypericumaceae ( Guttiferae AL de Juss).
nia mangostana Linn.). Further, one feature of the ultraviolet absorbent of the present invention is that the mangosteen-containing fraction of the Hypericumaceae plant ( Guttiferae AL de Juss) is an extracted fraction from the pericarp of the plant. The ultraviolet-absorbing external skin preparation of the present invention is characterized in that, in part, the above-mentioned ultraviolet-absorbing agent is blended, and in one, mangosteen ( Garcinia mangostana).
Linn.) Extract was added.
【0011】以下、本発明の実施の形態について詳述す
る。本発明者らは紫外線吸収剤の安全性という観点から
天然物質、特に植物を中心に広くその抽出物を検討し、
紫外線吸収能を有する物質の探索を行った。その結果、
オトギリソウ科植物の特定の画分に最大吸収波長が31
9nmでUV−A及びUV−B領域において優れた紫外線
吸収能が存在することを見い出し、その有効成分を特定
するとともに、安定性及び紫外線吸収能に優れ、しかも
光安定性においても優れた紫外線吸収剤及び皮膚外用剤
を完成した。The embodiments of the present invention will be described in detail below. From the viewpoint of the safety of the ultraviolet absorber, the present inventors have extensively studied the natural substance, particularly the extract thereof centering on plants,
We searched for substances that have ultraviolet absorption ability. as a result,
The maximum absorption wavelength is 31 in a specific fraction of Hypericum plants
It was found that there is an excellent UV absorption ability in the UV-A and UV-B regions at 9 nm, and the effective component is specified, and the stability and the UV absorption ability are excellent, and the UV absorption is also excellent in the light stability. Preparation and external preparation for skin were completed.
【0012】ここで、本発明で用いるオトギリソウ科植
物(Guttiferae A. L. deJuss)としてはフクギ属(Garcin
ia Linn.)に属するマンゴスチン(Garcinia mangostana
Linn.)、グルグル(Garcinia atroviridis Griff.ex T.
Anders.)、バンカマンギス(Garcinia bancana Miq.)、
コバノマンギス(Garcinia brevirostris Scheff.)、ゴ
ラカ(Garcinia cambogia Desr.)、セレベスマンゴスチ
ン(Garcinia celebicaLinn.)、コーワガンボジ(Garcini
a cowa Roxb.)、ムムンジン(Garcinia dioicaBlume.)、
オオバノマンゴスチン(Garcinia dulcis. Kurz.)、アカ
ミカンジス(Garcinia forbesii King.)、カンジス(Garc
inia globulosa Rindl.)、キミノマンギス(Garcinia gr
iffithii T. Anders.)、ガンボジ(Garcinia hauburyi H
ook. f.)、ハママンゴスチン(Garcinia hombroniana Pi
erre)、メルギーカンジス(Garcinia merguensis Wigh
t)、インドガムボジ(Garcinia morella Desr.)、ツノミ
マンギス(Garcinia nigrolineata Planch.ex T. Ander
s.)、コバノカンジス(Garcinia parvifolia Miq.)、ボ
タンマンゴスチン(Garcinia prainiana King)、フクギ
(Garcinia subelliptica Merrill)、キヤニモモ(Garcin
ia xanthochymus Hookf.)等が挙げられるが、中でもマ
ンゴスチン(Garcinia mangostana Linn.)が好ましい。
また、これら植物の用いる部位としては特に果皮が好適
である。Here, as a plant of the family Hypericum ( Guttiferae AL de Juss) used in the present invention, Garcin
ia Linn.) Garcinia mangostana
Linn.), Round (Garcinia atroviridis Griff.ex T.
Anders.), Bangka Manggis ( Garcinia bancana Miq.),
Kobanomangisu (Garcinia brevirostris Scheff.), Goraka (Garcinia cambogia Desr.), Celebes mangosteen (Garcinia celebica Linn.), Kowaganboji (Garcini
a cowa Roxb.), Mumunjin (Garcinia dioica Blume.),
Oba Roh mangosteen (Garcinia dulcis. Kurz.), Akamikanjisu (Garcinia forbesii King.), Kanjisu (Garc
inia globulosa Rindl.), Kimino Manggis ( Garcinia gr
iffithii T. Anders.), Garcinia hauburyi H
ook. f.), Hama Mangosteen ( Garcinia hombroniana Pi
erre), Merugikanjisu (Garcinia merguensis Wigh
t), Indogamuboji (Garcinia morella Desr.), Tsunomimangisu (Garcinia nigrolineata Planch.ex T. Ander
s.), Kobanokanjisu (Garcinia parvifolia Miq.), button mangosteen (Garcinia prainiana King), Garcinia
(Garcinia subelliptica Merrill), Kiyanimomo (Garcin
ia xanthochymus Hook f.) and the like, and among them, mangosteen ( Garcinia mangostana Linn.) is preferable.
Further, as a part used by these plants, the peel is particularly preferable.
【0013】本発明で用いる植物抽出物の製造方法とし
ては、前記植物を溶媒、例えば、メタノール、エタノー
ル、プロピルアルコール、イソプロピルアルコール、ブ
タノール、イソブタノール等の低級アルコール或いは含
水低級アルコール、プロピレングリコール、1,3−ブ
チレングリコール等の多価アルコール或いは含水多価ア
ルコール、アセトン、酢酸エチルエステル等の各種有機
溶媒により抽出し、溶媒を留去することにより得ること
ができる。そして、これら植物抽出物中の紫外線吸収能
を発揮する有効成分として下記化1の構造式で表される
マンゴスチンが確認された。The method for producing the plant extract used in the present invention is carried out by using the plant as a solvent, for example, lower alcohols such as methanol, ethanol, propyl alcohol, isopropyl alcohol, butanol and isobutanol, or hydrous lower alcohols, propylene glycol, 1 It can be obtained by extracting with a polyhydric alcohol such as 3,3-butylene glycol or a water-containing polyhydric alcohol, various organic solvents such as acetone and ethyl acetate, and distilling off the solvent. Then, mangosteen represented by the structural formula of the following chemical formula 1 was confirmed as an active ingredient exhibiting the ultraviolet absorbing ability in these plant extracts.
【化1】 Embedded image
【0014】マンゴスチンは既知の物質であるが、これ
までその紫外線吸収剤としての適性については全く知ら
れておらず、もちろん紫外線吸収性有効成分として紫外
線遮蔽効果を目的として皮膚外用剤等に配合されて用い
られたことはなかった。本発明者らは、オトギリソウ科
植物からの抽出画分に存在していた高い紫外線吸収能を
有する物質がマンゴスチンであることを突き止めるとと
もに、その光安定性が極めて優れていることをも見い出
し、マンゴスチンが紫外線吸収剤として優れた適性を有
していることを初めて明らかにしたものである。そし
て、このマンゴスチン又はマンゴスチンを含有する植物
抽出画分を紫外線吸収剤として配合すれば紫外線吸収能
が高く、しかも安全性及び光安定性に優れた皮膚外用剤
が得られる。Mangosteen is a known substance, but its suitability as a UV absorber has not been known at all until now, and of course, it has been blended as an UV-absorbing active ingredient in a skin external preparation or the like for the purpose of UV-shielding effect. Was never used. The present inventors have found that the substance having a high ultraviolet absorption capacity that was present in the extract fraction from Hypericumaceae plants was mangosteen, and also found that its photostability was extremely excellent, and mangosteen It has been clarified for the first time that has excellent suitability as an ultraviolet absorber. When this mangosteen or a plant extract fraction containing mangosteen is blended as an ultraviolet absorber, a skin external preparation having a high ultraviolet absorption ability and excellent safety and photostability can be obtained.
【0015】なお、本発明において用いられるマンゴス
チンとしては前記抽出方法によって得られるオトギリソ
ウ科植物抽出物を用いることができる。また、前記抽出
物はその色や匂いを除いてより使用しやすくするため
に、活性炭やカラムクロマトグラフィー等を用いて、本
発明の効果を損わない程度に精製を行っても良い。この
ような抽出精製物もまた、本発明の紫外線吸収剤及び皮
膚外用剤に用いることができる。もちろん、さらに精製
を行って単離したマンゴスチンを用いてもよい。また、
合成によってマンゴスチンを製造し、これを用いること
も可能である。As the mangosteen used in the present invention, the extract of Hypericumaceae plant obtained by the above extraction method can be used. In addition, the extract may be purified by using activated carbon, column chromatography or the like so as not to impair the effects of the present invention in order to remove the color and odor and make it easier to use. Such an extracted and purified product can also be used in the ultraviolet absorbent and the external skin preparation of the present invention. Of course, mangosteen isolated by further purification may be used. Also,
It is also possible to produce mangosteen by synthesis and use it.
【0016】本発明の皮膚外用剤全量における植物抽出
物の配合量は、乾燥物として0.005〜30重量%が
好ましい。配合量が0.005重量%未満であると紫外
線吸収効果が十分に発揮されず、また30重量%以上配
合してもコストが高くなり現実的でない。The content of the plant extract in the total amount of the external preparation for skin of the present invention is preferably 0.005 to 30% by weight as a dried product. If the blending amount is less than 0.005% by weight, the ultraviolet ray absorbing effect is not sufficiently exerted, and if it is blended in an amount of 30% by weight or more, the cost becomes high, which is not realistic.
【0017】また、本発明の紫外線吸収性皮膚外用剤は
前記の必須成分に加え、必要に応じて本発明の効果を損
わない範囲内で、化粧料、医薬部外品、医薬品等に一般
に用いられる各種成分、水性成分、保湿剤、増粘剤、防
腐剤、酸化防止剤、香料、色剤、薬剤等を配合すること
ができる。例えば、固体状或いは液状パラフィン、クリ
スタルオイル、セレシン、オゾケライト、モンタンロウ
等の炭化水素類、シリコン油類、オリーブ油、地ロウ、
カルナバロウ、ラノリンのような植物性もしくは動物性
油脂やロウ、更にステアリン酸、パルミチン酸、オレイ
ン酸、グリセリンモノステアリン酸エステル、グリセリ
ンモノオレイン酸エステル、イソプロピルミリスチン酸
プロピル、イソプロピルステアリン酸エステルのような
脂肪酸又はそのエステル類、分岐脂肪酸の一価アルコー
ル又は多価アルコールのエステル類、エチルアルコー
ル、イソプロピルアルコール、セチルアルコール、パル
ミチルアルコール等のアルコール類、グリコール、グリ
セリン、ソルビトール等の多価アルコール類又はそのエ
ステル類、非イオン性界面活性剤、アニオン性界面活性
剤、カチオン性界面活性剤のような界面活性剤を挙げる
ことができる。In addition to the above-mentioned essential components, the ultraviolet-absorbing external preparation for skin of the present invention is generally used in cosmetics, quasi-drugs, pharmaceuticals, etc., if necessary, within a range not impairing the effects of the present invention. Various components used, an aqueous component, a moisturizer, a thickener, an antiseptic, an antioxidant, a fragrance, a coloring agent, a drug and the like can be added. For example, solid or liquid paraffin, crystal oil, ceresin, ozokerite, hydrocarbons such as montan wax, silicone oils, olive oil, ground wax,
Vegetable or animal fats and oils such as carnauba wax and lanolin, and fatty acids such as stearic acid, palmitic acid, oleic acid, glycerin monostearate, glycerin monooleate, isopropyl isopropyl myristate, and isopropyl stearate. Or esters thereof, esters of monohydric alcohols or polyhydric alcohols of branched fatty acids, alcohols such as ethyl alcohol, isopropyl alcohol, cetyl alcohol and palmityl alcohol, polyhydric alcohols such as glycol, glycerin and sorbitol, or esters thereof. And surfactants such as nonionic surfactants, anionic surfactants, and cationic surfactants.
【0018】また、本発明には下記植物抽出物や薬剤も
適宜配合することができる。例えば、トウガラシ、ヨウ
テイ、アロエ、クコ、ヨモギ、カラシ、イネ、マンケイ
シ、マンネンロウ、コッサイホ、エニシダ、リンドウ、
タンジン、ヘチマ、キキョウ、マツ、クジン、ベニバ
ナ、メギ、ビンロウジ、ユーカリ、カゴソウ、モクロ
ウ、ゴシツ、サイコ、チャ、シンイ、ワサビ、ジョテイ
シ(ジョテイジツ)、オランダセンニチ、クチナシ、ウ
スバサイシン、ニンニク、ハッカ、ヨクイニン、キリン
ケツ、ヤシ、ゴボウ、カンゾウ、ホップ、キク、ラッキ
ョ、ニラ、ネギ、タマネギ、セネガ、アマチャヅル、マ
ンネンタケ、ジオウ、グリチルリチン酸モノアンモニウ
ム、グリチルレチン酸、グリチルリチン、ゴマ、センキ
ュウ、カシュウ等が挙げられる。In addition, the following plant extracts and medicines can be appropriately added to the present invention. For example, capsicum, youtei, aloe, wolfberry, mugwort, mustard, rice, mankeishi, mannen wax, kossai ho, nishida, gentian,
Tanjin, loofah, kyoto, pine, kujin, safflower, barberry, areca, eucalyptus, Kagosou, mokuro, goshitsu, psycho, cha, shinui, wasabi, joteishi, netherlands senchini, gardenia, usabasaicin, garlic, mint, Yokuinin, giraffe, coconut, burdock, licorice, hops, chrysanthemum, rakkyo, leek, leek, onion, senega, armchadul, mannoke mushroom, dio, monoammonium glycyrrhetinic acid, glycyrrhetinic acid, glycyrrhizinate, sesame, senkyu, kashi and the like.
【0019】また、本発明の紫外線吸収性皮膚外用剤の
剤型は任意であり、例えば液状、乳液状、クリーム状、
スティック状等の剤型をとることができる。以下、マン
ゴスチン(Garcinia mangostana Linn.)の果皮からの抽
出物を例として本発明をさらに具体的に説明する。Further, the dosage form of the ultraviolet absorbent external preparation for skin of the present invention is arbitrary, for example, liquid, emulsion, cream,
It is possible to take a dosage form such as a stick. Hereinafter, the present invention will be described in more detail with reference to an extract from the peel of mangosteen ( garcinia mangostana Linn.).
【0020】抽出例1 原料 マンゴスチン(Garcinia mangostana Linn.)の果皮粉砕
品100g 抽出 前記マンゴスチンの果皮粉砕品100gにイソプロピル
エーテル400mlを加え、温度50℃、時間1時間、
回転攪拌数100rpmで抽出操作を行った。 加圧濾過 前記で得られた抽出液を、窒素0.1kg/cm2以
下の加圧力を付加した状態で、濾紙No.2により濾過
を行った。 Extraction Example 1 Raw Material Mangosteen ( Garcinia mangostana Linn.) 100 g of crushed skin peeling Extraction 100 g of the crushed mangosteen skin was added with 400 ml of isopropyl ether, and the temperature was 50 ° C. for 1 hour.
The extraction operation was performed at a rotational stirring number of 100 rpm. Pressure filtration The extract obtained as described above was filtered under a pressure of nitrogen 0.1 kg / cm 2 or less. Filtered by 2.
【0021】濃縮 前記で得られた濾液について、温度45〜60℃、減
圧度35〜500torrで減圧濃縮を行った。 精製 前記濃縮物7.7gを活性炭10gで処理し、不純物を
除去した。次いで内径5cm、長さ50cmのクロマト管を
用いてシリカゲルカラムクロマトグラフィーで分離精製
を行った。展開溶媒は酢酸エチル−ヘキサン若しくはク
ロロホルム−メタノールを用いた。 加圧濾過 前記同様、窒素0.1kg/cm2以下の圧力で、濾紙
No.2を使用し、加圧濾過を行った。Concentration The filtrate obtained above was concentrated under reduced pressure at a temperature of 45 to 60 ° C. and a reduced pressure of 35 to 500 torr. Purification 7.7 g of the concentrate was treated with 10 g of activated carbon to remove impurities. Then, using a chromatographic tube having an inner diameter of 5 cm and a length of 50 cm, separation and purification was performed by silica gel column chromatography. As the developing solvent, ethyl acetate-hexane or chloroform-methanol was used. Pressure filtration Similarly to the above, filter paper No. 1 was used under a pressure of 0.1 kg / cm 2 or less of nitrogen. 2 was used and pressure filtration was performed.
【0022】この結果、マンゴスチンを主成分とする抽
出精製物3.85gが得られた。なお、前記抽出物の紫
外線吸収効果を有する主成分は、1H−NMR、GC−
MS、有機微量分析、紫外線吸収スペクトル(図1に示
す)、及び赤外吸収スペクトル等の解析によりマンゴス
チンであることが判明した。As a result, 3.85 g of an extracted and refined product containing mangosteen as a main component was obtained. In addition, the main component having the ultraviolet absorbing effect of the extract is 1 H-NMR, GC-
It was found to be mangosteen by MS, organic microanalysis, ultraviolet absorption spectrum (shown in FIG. 1), infrared absorption spectrum and the like.
【0023】抽出例2 原料 マンゴスチン(G. mangostana L.)の果皮粉砕品100g 抽出 前記マンゴスチンの果皮粉砕品100gにメタノール4
00mlを加え、温度50℃、時間1時間、回転攪拌数
100rpmで抽出操作を行った。 加圧濾過 前記で得られた抽出液を、窒素0.1kg/cm2以
下の加圧力を付加した状態で、濾紙No.2により濾過
を行った。 Extraction Example 2 100 g of crushed mangosteen (G. mangostana L.) peeled material 100 g of crushed mangosteen peeled product was added to 4 g of methanol
00 ml was added, and the extraction operation was performed at a temperature of 50 ° C. for a time of 1 hour and a rotational stirring number of 100 rpm. Pressure filtration The extract obtained as described above was filtered under a pressure of nitrogen 0.1 kg / cm 2 or less. Filtered by 2.
【0024】濃縮 前記で得られた濾液について、温度45〜60℃、減
圧度35〜500torrで減圧濃縮を行った。 精製 前記濃縮物7.7gを活性炭10gで処理し、不純物を
除去した。次いで内径5cm、長さ50cmのクロマト管を
用いてシリカゲルカラムクロマトグラフィーで分離精製
を行った。展開溶媒は酢酸エチル−ヘキサン若しくはク
ロロホルム−メタノールを用いた。 加圧濾過 前記同様、窒素0.1kg/cm2以下の圧力で、濾紙
No.2を使用し、加圧濾過を行った。Concentration The filtrate obtained above was concentrated under reduced pressure at a temperature of 45 to 60 ° C. and a vacuum degree of 35 to 500 torr. Purification 7.7 g of the concentrate was treated with 10 g of activated carbon to remove impurities. Then, using a chromatographic tube having an inner diameter of 5 cm and a length of 50 cm, separation and purification was performed by silica gel column chromatography. As the developing solvent, ethyl acetate-hexane or chloroform-methanol was used. Pressure filtration Similarly to the above, filter paper No. 1 was used under a pressure of 0.1 kg / cm 2 or less of nitrogen. 2 was used and pressure filtration was performed.
【0025】この結果、マンゴスチンを主成分とする抽
出精製物3.00gが得られた。なお、前記抽出物の紫
外線吸収効果を有する主成分は、1H−NMR、GC−
MS、有機微量分析、紫外線吸収スペクトル及び赤外吸
収スペクトル等の解析により抽出例1の場合と同様、マ
ンゴスチンであることが判明した。As a result, 3.00 g of an extracted and purified product containing mangosteen as a main component was obtained. In addition, the main component having the ultraviolet absorbing effect of the extract is 1 H-NMR, GC-
Similar to the case of Extraction Example 1, it was found to be mangostin by analysis of MS, organic trace analysis, ultraviolet absorption spectrum, infrared absorption spectrum, and the like.
【0026】次に、本発明者らはマンゴスチンの光安定
性について検討した。すなわち、マンゴスチンを濃度1
0ppmとなるようにエタノールに溶解し、このエタノ
ール溶液をガラス製サンプルビンに充填し、キセノンラ
ンプ光照射を50℃で30時間(夏場の約10日に相
当)行った。そして、前記同様に紫外線吸収スペクトル
を測定した。結果を図2及び図3に示す。同図からわか
るように、紫外線吸収スペクトルにおいてキセノンラン
プ光照射による吸光度低下はほとんど認められず、基本
的な波形も変化していなかった。以上のことから明らか
なように、マンゴスチンは優れた光安定性を有してお
り、紫外線吸収剤として高い適性を有することが分かっ
た。Next, the present inventors examined the photostability of mangosteen. That is, mangosteen at a concentration of 1
The solution was dissolved in ethanol to 0 ppm, the ethanol solution was filled in a glass sample bottle, and irradiation with xenon lamp light was performed at 50 ° C. for 30 hours (corresponding to about 10 days in summer). Then, the ultraviolet absorption spectrum was measured as described above. The results are shown in FIGS. 2 and 3. As can be seen from the figure, almost no decrease in absorbance due to irradiation with xenon lamp light was observed in the ultraviolet absorption spectrum, and the basic waveform did not change. As is clear from the above, it was found that mangosteen has excellent photostability and is highly suitable as an ultraviolet absorber.
【0027】次に本発明に係る皮膚外用剤の配合例を示
す。配合例1 クリーム A.油相 ステアリン酸 10.0重量% ステアリルアルコール 4.0 グリセリンモノステアリン酸エステル 8.0 ビタミンEアセテート 0.5 マンゴスチン果皮抽出物 0.03 香料 0.4 エチルパラベン 0.1 ブチルパラベン 0.1 プロピルパラベン 0.1 B.水相 1,3−ブチレングリコール 10.0 プロピレングリコール 8.0 グリセリン 2.0 水酸化カリウム 0.4 精製水 残 余Next, a compounding example of the external preparation for skin according to the present invention will be shown. Formulation Example 1 Cream A. Oil phase Stearic acid 10.0% by weight Stearyl alcohol 4.0 Glycerin monostearate 8.0 Vitamin E acetate 0.5 Mangosteen peel extract 0.03 Perfume 0.4 Ethylparaben 0.1 Butylparaben 0.1 Propyl Paraben 0.1 B. Aqueous phase 1,3-butylene glycol 10.0 Propylene glycol 8.0 Glycerin 2.0 Potassium hydroxide 0.4 Purified water Residual
【0028】〈製法〉油相Aと水相Bをそれぞれ70℃
に加熱し、完全溶解し、A相をB相に加えて、乳化機で
乳化した。乳化物を熱交換機を用いて冷却してクリーム
を得た。<Production Method> Oil phase A and water phase B are each 70 ° C.
The mixture was heated to 100 ° C., completely dissolved, and the phase A was added to the phase B and emulsified with an emulsifier. The emulsion was cooled using a heat exchanger to obtain a cream.
【0029】また、本配合例に係るクリームをマンゴス
チン果皮抽出物濃度が0.001%濃度溶液となるよう
にエタノールにて希釈し、石英セルに入れ、分光光度計
により200〜600nmの波長の吸光度を測定した結
果、抽出例1の紫外線吸収スペクトル(図1)と同様に
280〜370nm付近の波長領域において高い吸収能
を有し、日焼け防止等に効果があることが分かった。ま
た本配合例のクリームは保湿性にも優れていた。The cream according to the present formulation example was diluted with ethanol so that the mangosteen peel extract concentration became a 0.001% concentration solution, placed in a quartz cell, and the absorbance at a wavelength of 200 to 600 nm was measured by a spectrophotometer. As a result of the measurement, it was found that, like the ultraviolet absorption spectrum of Extraction Example 1 (FIG. 1), it has a high absorption ability in the wavelength region near 280 to 370 nm and is effective in preventing sunburn. Moreover, the cream of this formulation example was also excellent in moisture retention.
【0030】[0030]
【実施例】以下に本発明の実施例を挙げるが、本発明は
これらに限定されるものではない。また、配合量は他に
指定がない限り重量%で示す。以下の皮膚外用剤は何れ
も前記配合例1と同様、安全性が高く、紫外線吸収効果
に優れた皮膚外用剤であった。また、保湿性においても
優れた皮膚外用剤であった。EXAMPLES Examples of the present invention will be described below, but the present invention is not limited thereto. In addition, the compounding amount is shown by weight% unless otherwise specified. All of the following external preparations for skin were highly safe and were excellent in ultraviolet absorbing effect, as in the case of the above-mentioned formulation example 1. It was also an external preparation for skin, which was excellent in moisturizing property.
【0031】配合例2 クリーム A.油相 セタノール 4.0% ワセリン 7.0 イソプロピルミリステート 8.0 スクワラン 12.0 ジメチルポリシロキサン 3.0 グリセリンモノステアリン酸エステル 2.2 POE(20)ソルビタンモノステアレート 2.8 グリチルレチン酸ステアレート 0.02 エチルパラベン 0.1 ブチルパラベン 0.1 B.水相 マンゴスチン 0.1 1,3−ブチレングリコール 7.0 フェノキシエタノール 0.2 L−アスコルビン酸リン酸エステルマグネシウム塩 3.0 アスコルビン酸リン酸エステルマグネシウム塩 1.0 精製水 残 余 Formulation Example 2 Cream A. Oil phase Cetanol 4.0% Vaseline 7.0 Isopropyl myristate 8.0 Squalane 12.0 Dimethylpolysiloxane 3.0 Glycerin monostearate 2.2 POE (20) Sorbitan monostearate 2.8 Glycyrrhetinate stearate 0.02 ethyl paraben 0.1 butyl paraben 0.1 B. Water phase Mangosteen 0.1 1,3-butylene glycol 7.0 Phenoxyethanol 0.2 L-Ascorbic acid phosphoric acid ester magnesium salt 3.0 Ascorbic acid phosphoric acid ester magnesium salt 1.0 Purified water Residue
【0032】〈製法〉マンゴスチンに予め油相に溶解し
た後、配合例1に準じてクリームを得た。<Production Method> Mangosteen was dissolved in the oil phase in advance, and then a cream was obtained according to Formulation Example 1.
【0033】配合例3 乳液 A.油相 スクワラン 5.0% オレイルオレート 3.0 ワセリン 2.0 ソルビタンセスキオレイン酸エステル 0.8 ポリオキシエチレン(20)オレイルエーテル 1.2 2−エチルヘキシル−p−メトキシシンナメート 3.0 マンゴスチン果皮抽出物 0.2 香料 0.12 B.水相 ジプロピングリコール 5.0 エタノール 3.0 カルボキシルビニルポリマー 0.17 ヒアルロン酸ナトリウム 0.1 水酸化カリウム 0.08 メチルパラベン 0.15 ヘキサメタンリン酸ナトリウム 0.05 精製水 残 余 Formulation Example 3 Emulsion A. Oil phase Squalane 5.0% Oleyl oleate 3.0 Vaseline 2.0 Sorbitan sesquioleate 0.8 Polyoxyethylene (20) oleyl ether 1.2 2-Ethylhexyl-p-methoxycinnamate 3.0 Mangosteen peel extraction Material 0.2 Perfume 0.12 B. Water phase Dipropyne glycol 5.0 Ethanol 3.0 Carboxyl vinyl polymer 0.17 Sodium hyaluronate 0.1 Potassium hydroxide 0.08 Methylparaben 0.15 Sodium hexamethanephosphate 0.05 Purified water Residual
【0034】〈製法〉マンゴスチン果皮抽出物を予め油
相に溶解した後、配合例1に準じて乳液を得た。<Manufacturing Method> The mangosteen peel extract was previously dissolved in the oil phase, and then a milky lotion was obtained according to Formulation Example 1.
【0035】配合例4 クリーム A.油相 ベヘニルアルコール 0.5% 12-ヒト゛ロキシステアリン酸 コレスタノールエステル 2.0 スクワラン 7.0 ホホバオイル 5.0 自己乳化型モノステアリン酸グリセリル 2.5 ポリオキシエタレン(20) ソルビタンモノステアリン酸エステル 1.5 2−ヒドロキシ−4−メトキシベンゾフェノン 3.0 マンゴスチン果皮抽出物 0.05 エチルパラベン 0.2 ブチルパラベン 0.1 香料 0.1 B.水相 1,3−ブチレングリコール 6.0 グリセリン 3.5 亜鉛崋 1.5 カオリン 0.5 ベントナイト 0.3 ヘキサメタリン酸ナトリウム 0.03 精製水 残 余 Formulation Example 4 Cream A. Oil phase Behenyl alcohol 0.5% 12-Human doxystearic acid cholestanol ester 2.0 Squalane 7.0 Jojoba oil 5.0 Self-emulsifying glyceryl monostearate 2.5 Polyoxyethalene (20) sorbitan monostearate 1 .5 2-Hydroxy-4-methoxybenzophenone 3.0 Mangosteen peel extract 0.05 Ethylparaben 0.2 Butylparaben 0.1 Perfume 0.1 B.I. Aqueous phase 1,3-butylene glycol 6.0 Glycerin 3.5 Zinc oxide 1.5 Kaolin 0.5 Bentonite 0.3 Sodium hexametaphosphate 0.03 Purified water Residual
【0036】〈製法〉マンゴスチン果皮抽出物を油相に
溶解した後、配合例1に準じた製法で粉末入りクリーム
を得た。<Manufacturing Method> After dissolving the mangosteen peel extract in the oil phase, a cream containing powder was obtained by a manufacturing method according to Formulation Example 1.
【0037】配合例5 エッセンス A.油相 ステアリン酸 3.0% セタノール 1.0 ラノリン誘導体 3.0 流動パラフィン 5.0 2−エチルヘキシルステアレート 3.0 POEセチルアルコールエーテル 2.0 モノステアリン酸グリセリン 2.0 マンゴスチン果皮抽出物 10.0 防腐剤 適 量 香料 適 量 B.水相 1,3−ブチレングリコール 6.0 トリエタノールアミン 10.0 精製水 残 余 Formulation Example 5 Essence A. Oil phase Stearic acid 3.0% Cetanol 1.0 Lanolin derivative 3.0 Liquid paraffin 5.0 2-Ethylhexyl stearate 3.0 POE Cetyl alcohol ether 2.0 Glycerin monostearate 2.0 Mangosteen peel extract 10. 0 Preservative Suitable amount Perfume Suitable amount B. Water phase 1,3-butylene glycol 6.0 Triethanolamine 10.0 Purified water Residual
【0038】〈製法〉ステアリン酸、セタノール、ラノ
リン誘導体、流動パラフィン、2−エチルヘキシルステ
アレート、モノステアリン酸グリセリンを70〜80℃
にて加熱溶解後、マンゴスチン果皮抽出物を添加し、さ
らにPOEセチルアルコールエーテル、防腐剤、香料を
順次溶解し、温度を70℃にし、油相Aを製造した。水
相Bに攪拌しながら油相Aを添加し、乳化を行い、ホモ
ミキサーで乳化粒子を均一に調製後、脱気、冷却を行
い、エッセンスを得た。<Production Method> Stearic acid, cetanol, lanolin derivative, liquid paraffin, 2-ethylhexyl stearate, glycerin monostearate are added at 70 to 80 ° C.
After heat-dissolving in, the mangosteen peel extract was added, and further POE cetyl alcohol ether, preservative, and fragrance were sequentially dissolved, and the temperature was raised to 70 ° C. to produce oil phase A. The oil phase A was added to the aqueous phase B with stirring to emulsify, and the emulsion particles were uniformly prepared with a homomixer, followed by degassing and cooling to obtain an essence.
【0039】配合例6 エッセンス A.エタノール相 ソルビタンモノオレイン酸エステル 1.0% オレイルアルコール 0.5 ビタミンEアセテート 0.2 香料 適 量 エタノール 10.0 POEソルビタンジラウレート モノステアリン酸エステル 1.0 防腐剤 適 量 退色防止剤 適 量 B.水相 マンゴスチン果皮抽出物 0.05 ジプロピレングリコール 5.0 ポリエチレングリコール400 5.0 カルボキシビニルポリマー 0.3 アルギン酸ナトリウム 0.3 水酸化カリウム 0.15 POEソルビタンジラウレート モノステアリン酸エステル 1.0 プラセンタエキス 0.2 精製水 残 余 Formulation 6 Essence A. Ethanol phase Sorbitan monooleate 1.0% Oleyl alcohol 0.5 Vitamin E acetate 0.2 Perfume proper amount Ethanol 10.0 POE sorbitan dilaurate monostearate ester 1.0 Preservative proper amount anti-fading agent proper amount B. Water phase Mangosteen peel extract 0.05 Dipropylene glycol 5.0 Polyethylene glycol 400 5.0 Carboxyvinyl polymer 0.3 Sodium alginate 0.3 Potassium hydroxide 0.15 POE sorbitan dilaurate monostearate 1.0 Placenta extract 0.2 Purified water Residual
【0040】〈製法〉精製水にカルボキシビニルポリマ
ーを溶解した後、ジプロピレングリコール、ポリエチレ
ングリコール400、マンゴスチン果皮抽出物を順次溶
解し、水相Bを得た。エタノールにPOEソルビタンジ
ラウレートモノステアリン酸エステル、ソルビタンモノ
オレイン酸エステル、オレイルアルコール、ビタミンE
アセテート、香料、防腐剤、退色防止剤を順次溶解し、
エタノール相Aを得、該エタノール相Aを水相Bに添加
し乳化した。精製水の一部に水酸化カリウムを溶解し、
これを添加して攪拌、脱気、濾過し、エッセンスを得
た。<Manufacturing Method> After dissolving the carboxyvinyl polymer in purified water, dipropylene glycol, polyethylene glycol 400 and mangosteen peel extract were successively dissolved to obtain an aqueous phase B. Ethanol POE sorbitan dilaurate monostearate, sorbitan monooleate, oleyl alcohol, vitamin E
Acetate, fragrance, antiseptic, anti-fading agent are sequentially dissolved,
An ethanol phase A was obtained, and the ethanol phase A was added to the aqueous phase B and emulsified. Dissolve potassium hydroxide in a portion of purified water,
This was added, stirred, degassed, and filtered to obtain an essence.
【0041】配合例7 水中油型ファンデーション A.粉体 タルク 3.0% 二酸化チタン 5.0 ベンガラ 0.5 黄酸化鉄 1.4 黒酸化鉄 0.1 B.水相 ベントナイト 0.5 モノステアリン酸ポリオキシエチレンソルビタン 0.9 トリエタノールアミン 1.0 プロピレングリコール 10.0 マンゴスチン果皮抽出物 0.1 精製水 56.4 C.油相 ステアリン酸 2.2 イソヘキサデシルアルコール 7.0 モノステアリン酸グリセリン 2.0 液状ラノリン 2.0 流動パラフィン 8.0 防腐剤 適 量 香料 適 量 Formulation Example 7 Oil-in-water foundation A. Powder talc 3.0% Titanium dioxide 5.0 Red iron oxide 0.5 Yellow iron oxide 1.4 Black iron oxide 0.1 B. Water phase Bentonite 0.5 Polyoxyethylene sorbitan monostearate 0.9 Triethanolamine 1.0 Propylene glycol 10.0 Mangosteen peel extract 0.1 Purified water 56.4 C.I. Oil phase Stearic acid 2.2 Isohexadecyl alcohol 7.0 Glycerin monostearate 2.0 Liquid lanolin 2.0 Liquid paraffin 8.0 Preservative proper amount Perfume proper amount
【0042】〈製法〉予めマンゴスチン果皮抽出物を一
部プロピレングリコールに溶解し、また水相の増粘剤で
あるベントナイトを残部プロピレングリコールに分散し
た。これらを精製水に加え、70℃でホモミキサー処理
した後、残りの水相成分を添加し十分に攪拌した。これ
に十分混合粉砕された粉体部を攪拌しながら添加し、7
0℃でホモミキサー処理した。次に70℃〜80℃で加
熱溶解された油相を徐々に添加し70℃でホモミキサー
処理した。これを攪拌しながら冷却し、45℃で香料を
加え、室温まで冷却、最後に脱気し容器に充填して水中
油型ファンデーションを得た。<Manufacturing Method> The mangosteen peel extract was partially dissolved in propylene glycol in advance, and bentonite, which is a thickener for the aqueous phase, was dispersed in the rest of propylene glycol. These were added to purified water and subjected to a homomixer treatment at 70 ° C, and then the remaining aqueous phase components were added and sufficiently stirred. Add the powder portion that has been thoroughly mixed and pulverized to this while stirring,
A homomixer treatment was performed at 0 ° C. Next, the oil phase heated and dissolved at 70 ° C. to 80 ° C. was gradually added and subjected to a homomixer treatment at 70 ° C. This was cooled with stirring, a fragrance was added at 45 ° C., cooled to room temperature, finally deaerated and filled in a container to obtain an oil-in-water foundation.
【0043】配合例8 W/O型ファンデーション(クリームタイプ) A.粉体 セリサイト 5.36% カオリン 4.0 二酸化チタン 9.32 ベンガラ 0.36 黄酸化鉄 0.8 黒酸化鉄 0.16 B.油相 流動パラフィン 5.0 マンゴスチン果皮抽出物 0.08 デカメチルシクロペンタシロキサン 12.0 ポリオキシエチレン変性ジメチルポリシロキサン 4.0 精製水 51.9 C.水相 分散剤 0.1 1,3−ブチレングリコール 5.0 精製水 51.9 防腐剤 適 量 D.その他 安定化剤 2.0 香料 適 量 Formulation Example 8 W / O type foundation (cream type) A. Powder sericite 5.36% Kaolin 4.0 Titanium dioxide 9.32 Red iron oxide 0.36 Yellow iron oxide 0.8 Black iron oxide 0.16 B. Oil phase Liquid paraffin 5.0 Mangosteen peel extract 0.08 Decamethylcyclopentasiloxane 12.0 Polyoxyethylene-modified dimethylpolysiloxane 4.0 Purified water 51.9 C.I. Aqueous phase dispersant 0.1 1,3-butylene glycol 5.0 Purified water 51.9 Preservative proper amount D.I. Other stabilizers 2.0 Fragrance suitable amount
【0044】〈製法〉水相を70℃で加熱攪拌後、十分
混合粉砕された粉体部を添加し70℃でホモミキサー処
理した。これに一部の精製水に溶解した安定化剤を加え
攪拌した。更に70℃に加熱した油相を加え、70℃で
ホモミキサー処理した。これを攪拌しながら冷却し45
℃で香料を加え、室温まで冷却、最後に脱気し容器に充
填してW/O乳化型ファンデーションを得た。<Manufacturing Method> The aqueous phase was heated and stirred at 70 ° C., and the powder portion which had been sufficiently mixed and pulverized was added, and the mixture was treated with a homomixer at 70 ° C. A stabilizer dissolved in a part of purified water was added to this and stirred. Further, the oil phase heated to 70 ° C. was added, and the mixture was treated with a homomixer at 70 ° C. Cool this while stirring 45
A fragrance was added at 0 ° C., the mixture was cooled to room temperature, and finally deaerated and filled in a container to obtain a W / O emulsion type foundation.
【0045】配合例9 W/O型クリームタイプサンスクリーン化粧料 A.水相 精製水 54.95% 1,3−ブチレングリコール 7.0 二酸化チタン 5.0 エデト酸二ナトリウム 0.05 エタノール 2.0 ゲッキツ根抽出物 0.5 B.油相 オキシベンゾン 2.0 パラメトキシケイ皮酸オクチル 5.0 ワセリン 5.0 ステアリルアルコール 3.0 マンゴスチン果皮抽出物 14.95 ステアリン酸 3.0 グリセリルモノステアレート 3.0 ポリアクリル酸エチル 1.0 酸化防止剤 適 量 防腐剤 適 量 香料 適 量 Formulation Example 9 W / O type cream type sunscreen cosmetic A. Aqueous phase Purified water 54.95% 1,3-Butylene glycol 7.0 Titanium dioxide 5.0 Disodium edetate 0.05 Ethanol 2.0 Gecchi root extract 0.5 B.I. Oil phase Oxybenzone 2.0 Octyl paramethoxycinnamate 5.0 Vaseline 5.0 Stearyl alcohol 3.0 Mangosteen peel extract 14.95 Stearic acid 3.0 Glyceryl monostearate 3.0 Polyethyl acrylate 1.0 Antioxidant Appropriate amount Preservative Appropriate amount Perfume Appropriate amount
【0046】〈製法〉ゲッキツ根抽出物は予めエタノー
ルに溶解しておいた。油相部と水相部をそれぞれ70℃
に加熱し溶解させた。水相部は二酸化チタンの分散を十
分に行い、油相部を加え、ホモジナイザーを用いて乳化
した。乳化物を熱交換機を用い冷却し、W/Oクリーム
タイプサンスクリーン化粧料を得た。<Manufacturing Method> The radix root extract was previously dissolved in ethanol. Oil phase and water phase are 70 ℃
It was heated to and dissolved. Titanium dioxide was sufficiently dispersed in the water phase portion, the oil phase portion was added, and the mixture was emulsified using a homogenizer. The emulsion was cooled using a heat exchanger to obtain a W / O cream type sunscreen cosmetic.
【0047】配合例10 O/W型乳液タイプサンスクリーン化粧料 A.水相 精製水 68.3% ジプロピレングリコール 6.0 エタノール 3.0 ヒドロキシエチルセルロース 0.3 マンゴスチン果皮抽出物 0.005 B.油相 パラメトキシケイ皮酸オクチル 6.0 ジパラメトキシケイ皮酸グリセリルオクチル 2.0 4-tert-ブチル4′-メトキシベンゾイルメタン 2.0 オキシベンゾン 3.0 オレイルオレート 5.0 ジメチルポリシロキサン 3.0 ワセリン 0.5 セチルアルコール 1.0 ソルビタンセスキオレイン酸エステル 0.8 POE(29)オレイルアルコールエーテル 1.2 酸化防止剤 適 量 防腐剤 適 量 香料 適 量 Formulation Example 10 O / W type emulsion type sunscreen cosmetic A. Aqueous phase Purified water 68.3% Dipropylene glycol 6.0 Ethanol 3.0 Hydroxyethyl cellulose 0.3 Mangosteen peel extract 0.005 B.I. Oil phase Octyl paramethoxycinnamate 6.0 Glyceryloctyl diparamethoxycinnamate 2.0 4-tert-Butyl 4′-methoxybenzoylmethane 2.0 Oxybenzone 3.0 Oleyloleate 5.0 Dimethylpolysiloxane 3. 0 Vaseline 0.5 Cetyl alcohol 1.0 Sorbitan sesquioleate ester 0.8 POE (29) oleyl alcohol ether 1.2 Antioxidant proper amount Preservative proper amount Perfume proper amount
【0048】〈製法〉マンゴスチン果皮抽出物を予めエ
タノールに溶解し、更に他の水相成分と合わせて70℃
に加熱し、水相を調製した。そして、油相部を70℃に
加熱溶解させた。水相部に油相部を加え、ホモジナイザ
ーを用い乳化した。乳化物を熱交換機を用い冷却した。<Manufacturing Method> The mangosteen peel extract is dissolved in ethanol in advance, and it is further combined with other aqueous phase components at 70 ° C.
The mixture was heated to 1, and an aqueous phase was prepared. Then, the oil phase portion was heated and dissolved at 70 ° C. The oil phase part was added to the water phase part and emulsified using a homogenizer. The emulsion was cooled using a heat exchanger.
【0049】配合例11 W/O型クリームタイプサンスクリーン化粧料 A.水相 精製水 36.5% 1,3−ブチレングリコール 6.0 B.油相 パラメトキシケイ皮酸オクチル 5.0 オキシベンゾン 3.0 4-tert-ブチル4′-メトキジベンゾイルメタン 1.0 疎水化処理二酸化チタン 3.0 スクワラン 40.0 マンゴスチン果皮抽出物 1.0 ジイソステアリン酸グリセリン 3.0 有機変性モンモリロナイト 1.5 防腐剤 適 量 香料 適 量 Formulation Example 11 W / O type cream type sunscreen cosmetic A. Aqueous phase Purified water 36.5% 1,3-butylene glycol 6.0 B.I. Oil phase Octyl paramethoxycinnamate 5.0 Oxybenzone 3.0 4-tert-Butyl 4'-methokidibenzoylmethane 1.0 Hydrophobized titanium dioxide 3.0 Squalane 40.0 Mangosteen peel extract 1.0 Diisostearin Acid glycerin 3.0 Organically modified montmorillonite 1.5 Preservative Suitable amount Perfume Suitable amount
【0050】〈製法〉油相部と水相部をそれぞれ70℃
に加熱溶解させた。油相部は二酸化チタンの分散を十分
に行い、ホモジナイザー処理を行いながら水相部を添加
した。乳化物を熱交換機を用い冷却した。<Production Method> The oil phase part and the water phase part are each 70 ° C.
It was heated to dissolve. Titanium dioxide was sufficiently dispersed in the oil phase portion, and the water phase portion was added while performing the homogenizer treatment. The emulsion was cooled using a heat exchanger.
【0051】配合例12 ローション 精製水 40.0% ジプロピレングリコール 5.0 1,3−ブチレングリコール 10.0 ポリエチレングリコール400 10.0 エチルアルコール 20.0 ポリオキシエチレン(60)硬化ヒマシ油 3.0 パラメトキシケイ皮酸オクチル 1.0 マンゴスチン果皮抽出物 5.0 トリエタノールアミン 5.0 香料 適 量 Formulation Example 12 Lotion Purified water 40.0% Dipropylene glycol 5.0 1,3-butylene glycol 10.0 Polyethylene glycol 400 10.0 Ethyl alcohol 20.0 Polyoxyethylene (60) hydrogenated castor oil 3. 0 Octyl paramethoxycinnamate 1.0 Mangosteen peel extract 5.0 Triethanolamine 5.0 Fragrance Suitable amount
【0052】〈製法〉エチルアルコールにポリオキシエ
チレン(60)硬化ヒマシ油、パラメトキシケイ皮酸オ
クチル及び香料を溶解した(アルコール相)。一方、
1,3−ブチレングリコールにゲッキツ根抽出物を予め
溶解し、更に精製水とその他の多価アルコールを添加
し、十分に溶解させた(水相)。水相にアルコール相を
添加し、充分に攪拌した。<Production Method> Polyoxyethylene (60) hydrogenated castor oil, octyl paramethoxycinnamate and a fragrance were dissolved in ethyl alcohol (alcohol phase). on the other hand,
The Geckitz root extract was dissolved in 1,3-butylene glycol in advance, and purified water and other polyhydric alcohols were further added and sufficiently dissolved (aqueous phase). The alcohol phase was added to the aqueous phase, and the mixture was thoroughly stirred.
【0053】配合例13 O/W型乳液タイプサンスクリーン化粧料 A.油相 流動パラフィン 3.0% ミリスチン酸イソプロピル 2.0 オレイルオレエート 4.0 ワセリン 2.0 ステアリルアルコール 1.0 ステアリン酸 2.0 グリセリルモノステアレート 2.0 マンゴスチン果皮抽出物 0.1 ビタミンEアセテート 適 量 防腐剤 適 量 香料 適 量 B.水相 精製水 77.8 1,3−ブチレングリコール 6.0 カルボキシビニルポリマー 0.2 トリエタノールアミン 適 量 Formulation Example 13 O / W type emulsion type sunscreen cosmetic A. Oil phase Liquid paraffin 3.0% Isopropyl myristate 2.0 Oleyl oleate 4.0 Vaseline 2.0 Stearyl alcohol 1.0 Stearic acid 2.0 Glyceryl monostearate 2.0 Mangosteen peel extract 0.1 Vitamin E Acetate Proper amount Preservative Proper amount Perfume Proper amount B. Water phase Purified water 77.8 1,3-Butylene glycol 6.0 Carboxyvinyl polymer 0.2 Triethanolamine Appropriate amount
【0054】〈製法〉油相部と水相部をそれぞれ70℃
に加熱溶解させた。水相に油相を加え、ホモジナイザー
を用い乳化した。乳化物を熱交換機を用い冷却した。<Production method> The oil phase part and the water phase part are each 70 ° C.
It was heated to dissolve. The oil phase was added to the aqueous phase, and the mixture was emulsified using a homogenizer. The emulsion was cooled using a heat exchanger.
【0055】[0055]
【発明の効果】以上説明したように本発明に係る紫外線
吸収剤及びそれを配合した皮膚外用剤によれば、マンゴ
スチンあるいはこれを主成分とする植物抽出物を配合す
ることにより安全性、光安定性が高く、しかも優れた紫
外線吸収効果を得ることができる。As described above, according to the ultraviolet absorbent and the external skin preparation containing the same according to the present invention, the safety and photostability can be improved by adding mangosteen or a plant extract containing it as a main component. It has high properties and can obtain an excellent ultraviolet absorbing effect.
【図1】本発明の一実施例に係るマンゴスチン(Garcini
a mangostana Linn.)の果皮のイソプロピルエーテル抽
出物(抽出例1)の紫外線吸収スペクトル図である。FIG. 1 shows a mangosteen ( Garcini) according to an embodiment of the present invention.
FIG. 3 is an ultraviolet absorption spectrum diagram of an isopropyl ether extract (Extraction Example 1) of the skin of a mangostana Linn.).
【図2】マンゴスチンのキセノンランプ照射前の紫外線
吸収スペクトル図である。FIG. 2 is an ultraviolet absorption spectrum diagram of mangosteen before irradiation with a xenon lamp.
【図3】マンゴスチンのキセノンランプ照射後の紫外線
吸収スペクトル図である。FIG. 3 is an ultraviolet absorption spectrum diagram of mangosteen after irradiation with a xenon lamp.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 谷口 和世 神奈川県横浜市港北区新羽町1050番地 株 式会社資生堂第一リサーチセンター内 (72)発明者 西 豊行 京都府京都市山科区大宅坂の辻町39 日本 新薬株式会社内 ─────────────────────────────────────────────────── ─── Continued Front Page (72) Inventor Kazuyo Taniguchi 1050 Shinba-cho, Kohoku-ku, Yokohama-shi, Kanagawa Shiseido Daiichi Research Center Co., Ltd. (72) Toyoyuki Nishi, Oyazaka, Yamashina-ku, Kyoto-shi, Kyoto 39 Tsunomachi, Nippon Shinyaku Co., Ltd.
Claims (8)
ことを特徴とする紫外線吸収剤。1. An ultraviolet absorber containing mangosteen as an active ingredient.
オトギリソウ科植物(Guttiferae A. L. deJuss)のマン
ゴスチン含有画分を配合したことを特徴とする紫外線吸
収剤。2. The ultraviolet absorber according to claim 1, wherein
An ultraviolet absorber comprising a mangosteen-containing fraction of a plant of the family Hypericum ( Guttiferae AL de Juss).
オトギリソウ科植物(Guttiferae A. L. deJuss)がフク
ギ属(Garcinia Linn.)植物であることを特徴とする紫外
線吸収剤。3. The ultraviolet absorber according to claim 2, wherein
An ultraviolet absorber characterized in that the Hypericumaceae plant ( Guttiferae AL de Juss) is a plant of the genus Garcinia Linn.
いて、オトギリソウ科植物(Guttiferae A. L. deJuss)
がフクギ属(Garcinia Linn.)に属するマンゴスチン(Gar
cinia mangostana Linn.)、グルグル(Garcinia atrovir
idis Griff.ex T. Anders.)、バンカマンギス(Garcinia
bancana Miq.)、コバノマンギス(Garcinia brevirostr
is Scheff.)、ゴラカ(Garcinia cambogia Desr.)、セレ
ベスマンゴスチン(Garcinia celebica Linn.)、コーワ
ガンボジ(Garcinia cowa Roxb.)、ムムンジン(Garcinia
dioica Blume.)、オオバノマンゴスチン(Garcinia dul
cis. Kurz.)、アカミカンジス(Garcinia forbesii Kin
g.)、カンジス(Garcinia globulosa Rindl.)、キミノマ
ンギス(Garcinia griffithii T. Anders.)、ガンボジ(G
arcinia hauburyi Hook. f.)、ハママンゴスチン(Garci
nia hombroniana Pierre)、メルギーカンジス(Garcinia
merguensis Wight)、インドガムボジ(Garcinia morell
a Desr.)、ツノミマンギス(Garcinia nigrolineata Pla
nch.ex T. Anders.)、コバノカンジス(Garcinia parvif
olia Miq.)、ボタンマンゴスチン(Garcinia prainiana
King)、フクギ(Garcinia subelliptica Merrill)、キヤ
ニモモ(Garcinia xanthochymus Hook f.)の中から選ば
れた少なくとも1種以上の植物抽出物であることを特徴
とする紫外線吸収剤。4. The ultraviolet absorber according to claim 2 or 3, wherein the Hypericumaceae plant ( Guttiferae AL de Juss) is used.
There mangosteen belonging to the Garcinia (Garcinia Linn.) (Gar
cinia mangostana Linn.), round (Garcinia atrovir
idis Griff.ex T. Anders.), Bankamangisu (Garcinia
bancana Miq.), Cobano Manggis ( Garcinia brevirostr )
is Scheff.), Goraka ( Garcinia cambogia Desr.), Celebes Mangosteen ( Garcinia celebica Linn.), Kowa Gamboji ( Garcinia cowa Roxb.), Mumunjin ( Garcinia )
dioica Blume.), Obana mangosteen ( Garcinia dul)
cis. Kurz.), Akamikanjisu (Garcinia forbesii Kin
g.), Kanjisu (Garcinia globulosa Rindl.), Kiminomangisu (Garcinia griffithii T. Anders.), Ganboji (G
arcinia hauburyi Hook. f.), Hama Mangosteen ( Garci
nia hombroniana Pierre), Merugikanjisu (Garcinia
merguensis Wight), Indogamuboji (Garcinia morell
a Desr.), Tsunomimangisu (Garcinia nigrolineata Pla
nch.ex T. Anders.), Covanocandis ( Garcinia parvif )
olia Miq.), button mangosteen ( Garcinia prainiana
King), Fukugi ( Gardinia subelliptica Merrill), and peach ( Gardinia xanthochymus Hook f.) At least one or more kinds of plant extract selected from the ultraviolet absorber characterized by the above-mentioned.
オトギリソウ科植物(Guttiferae A. L. deJuss)がフク
ギ属(Garcinia Linn.)に属するマンゴスチン(Garcinia
mangostana Linn.)であることを特徴とする紫外線吸収
剤。5. The ultraviolet absorber according to claim 2, wherein
Mangosteen belonging to hypericaceae plant (Guttiferae AL deJuss) is Garcinia (Garcinia Linn.) (Garcinia
Mangostana Linn.) UV absorber.
収剤において、オトギリソウ科植物(Guttiferae A. L.
deJuss)のマンゴスチン含有画分が該植物の果皮からの
抽出画分であることを特徴とする紫外線吸収剤。6. The ultraviolet absorber according to claim 2, wherein the Hypericumaceae plant ( Guttiferae AL) is used.
de Juss) mangosteen-containing fraction is an extract fraction from the pericarp of the plant.
収剤を配合したことを特徴とする皮膚外用剤。7. An external preparation for skin, comprising the ultraviolet absorbent according to claim 1 incorporated therein.
n.)の抽出物を配合したことを特徴とする紫外線吸収性
皮膚外用剤。8. A mangostin ( garcinia mangostana Lin
An ultraviolet-absorptive external preparation for skin, comprising the extract of n.).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7274784A JPH0987155A (en) | 1995-09-27 | 1995-09-27 | Ultraviolet light absorber and skin preparation for external use obtained by blending the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7274784A JPH0987155A (en) | 1995-09-27 | 1995-09-27 | Ultraviolet light absorber and skin preparation for external use obtained by blending the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0987155A true JPH0987155A (en) | 1997-03-31 |
Family
ID=17546520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7274784A Withdrawn JPH0987155A (en) | 1995-09-27 | 1995-09-27 | Ultraviolet light absorber and skin preparation for external use obtained by blending the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0987155A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2754447A1 (en) * | 1996-10-16 | 1998-04-17 | Codif International Sa | Sun-cream preparation |
| JP2002029986A (en) * | 2000-07-19 | 2002-01-29 | Pola Chem Ind Inc | Corium collagen fiber bundle-restructuring agent and composition containing the same |
| JP2002047125A (en) * | 2000-05-26 | 2002-02-12 | Shiseido Co Ltd | Skin care preparation for inhibiting sebum secretion |
| JP2002047180A (en) * | 2000-08-02 | 2002-02-12 | Lotte Co Ltd | Cyclooxygenase inhibitor and food and drink containing it |
| WO2003047565A1 (en) * | 2001-12-05 | 2003-06-12 | Sakamoto Bio Co., Ltd. | Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives |
| WO2003057141A3 (en) * | 2001-12-27 | 2004-02-12 | Avon Prod Inc | Methods for improving the aesthetic appearance of skin |
| WO2010114149A1 (en) | 2009-03-31 | 2010-10-07 | 株式会社ロッテ | Composition for treatment and/or prevention of dermatopathy |
| WO2013005281A1 (en) | 2011-07-01 | 2013-01-10 | 株式会社資生堂 | Platelet-derived growth factor-bb production promoter, and mesenchymal stem cell production promoter, stem cell stabilizer and dermis regenerator each comprising same |
| CN103356442A (en) * | 2013-08-06 | 2013-10-23 | 李卫旗 | Production method for sunscreen cream with plant extracts as main functional components |
| JP2016069334A (en) * | 2014-09-30 | 2016-05-09 | 株式会社ダリヤ | Hair-growing cosmetics |
| US10022412B2 (en) | 2014-09-16 | 2018-07-17 | Medi Bio Lab. Co., Ltd. | Composition for preventing or alleviating periodontal diseases, containing, as active ingredient, mangosteen extract or α- or γ-mangosteen |
-
1995
- 1995-09-27 JP JP7274784A patent/JPH0987155A/en not_active Withdrawn
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2754447A1 (en) * | 1996-10-16 | 1998-04-17 | Codif International Sa | Sun-cream preparation |
| JP2002047125A (en) * | 2000-05-26 | 2002-02-12 | Shiseido Co Ltd | Skin care preparation for inhibiting sebum secretion |
| JP2002029986A (en) * | 2000-07-19 | 2002-01-29 | Pola Chem Ind Inc | Corium collagen fiber bundle-restructuring agent and composition containing the same |
| JP2002047180A (en) * | 2000-08-02 | 2002-02-12 | Lotte Co Ltd | Cyclooxygenase inhibitor and food and drink containing it |
| CN1297268C (en) * | 2001-12-05 | 2007-01-31 | 坂本生物科技有限公司 | Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives |
| JPWO2003047565A1 (en) * | 2001-12-05 | 2005-04-14 | 株式会社坂本バイオ | Melanin production inhibitor and whitening agent comprising egonol derivative, and composition containing egonol derivative |
| WO2003047565A1 (en) * | 2001-12-05 | 2003-06-12 | Sakamoto Bio Co., Ltd. | Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives |
| JP4632115B2 (en) * | 2001-12-05 | 2011-02-16 | 株式会社坂本バイオ | Melanin production inhibitor and whitening agent comprising egonol derivative, and composition containing egonol derivative |
| WO2003057141A3 (en) * | 2001-12-27 | 2004-02-12 | Avon Prod Inc | Methods for improving the aesthetic appearance of skin |
| JP2005518399A (en) * | 2001-12-27 | 2005-06-23 | エイボン プロダクツ インコーポレーテッド | Method for improving the aesthetic appearance of the skin |
| WO2010114149A1 (en) | 2009-03-31 | 2010-10-07 | 株式会社ロッテ | Composition for treatment and/or prevention of dermatopathy |
| CN102365090A (en) * | 2009-03-31 | 2012-02-29 | 罗蒂株式会社 | Composition for treatment and/or prevention of dermatopathy |
| JPWO2010114149A1 (en) * | 2009-03-31 | 2012-10-11 | 株式会社ロッテ | Composition for treatment and / or prevention of skin disorders |
| WO2013005281A1 (en) | 2011-07-01 | 2013-01-10 | 株式会社資生堂 | Platelet-derived growth factor-bb production promoter, and mesenchymal stem cell production promoter, stem cell stabilizer and dermis regenerator each comprising same |
| CN103356442A (en) * | 2013-08-06 | 2013-10-23 | 李卫旗 | Production method for sunscreen cream with plant extracts as main functional components |
| US10022412B2 (en) | 2014-09-16 | 2018-07-17 | Medi Bio Lab. Co., Ltd. | Composition for preventing or alleviating periodontal diseases, containing, as active ingredient, mangosteen extract or α- or γ-mangosteen |
| JP2016069334A (en) * | 2014-09-30 | 2016-05-09 | 株式会社ダリヤ | Hair-growing cosmetics |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2858961B2 (en) | Cosmetic or pharmaceutical composition containing mangiferin or its derivative as active ingredient in pure form or as plant extract | |
| JPH07118132A (en) | Ultraviolet-absorbing skin cosmetic | |
| JPH0987155A (en) | Ultraviolet light absorber and skin preparation for external use obtained by blending the same | |
| JPH04244004A (en) | Cosmetic | |
| JPH06336417A (en) | Ultraviolet light absorber and external preparation for skin mixed with the same | |
| JP2009029734A (en) | External preparation for skin | |
| JP4953216B2 (en) | Whitening composition | |
| JPH08175957A (en) | Topical skin | |
| KR102389168B1 (en) | Double pickering emulsion type sunscreen cosmetic composition | |
| DE10062401A1 (en) | Use of folic acid and / or derivatives thereof for the preparation of cosmetic or dermatological preparations for the prophylaxis of damage to the skin's own DNA and / or to repair damage already occurred to the skin's own DNA | |
| JPH08157346A (en) | Ultraviolet absorbing skin cosmetic | |
| JPH07165527A (en) | Ultraviolet-absorbing skin cosmetic | |
| JP3453227B2 (en) | Ultraviolet absorber and external preparation for skin containing the same | |
| JPH11349435A (en) | External preparation for skin effective for preventing and improving pigmentation symptoms caused by ultraviolet rays | |
| JPH08268836A (en) | Ultraviolet light-absorbing skin cosmetic | |
| JPH07165528A (en) | Ultraviolet-absorbing skin cosmetic | |
| KR101086224B1 (en) | Cosmetic composition for sunscreen containing a film-forming polymer to which the lilac extract is added | |
| JP4880233B2 (en) | Anti-dermatological agent and external preparation for skin containing the same | |
| JP2007262008A (en) | UV absorber comprising arbutin caffeic acid ester and cosmetics containing the same | |
| JP2700601B2 (en) | Natural UV absorbers and cosmetics containing them | |
| JP2004331602A (en) | External preparation for skin | |
| JP3119622B2 (en) | Cosmetics | |
| JP4103727B2 (en) | UV protection agent | |
| JPH1045528A (en) | Antioxidant | |
| JPH06321760A (en) | Skin beautifying agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20021203 |